// App-Quantinova.ai

PB0056 : Bleeding risk of intramuscular injection of COVID-19 vaccines in adult patients with therapeutic anticoagulation

Researchers

Presenter

  • N. Gendron

Principal Investigators

  • L. Khider

  • B. Bertin

  • T. Mirault

  • D. Smadja

  • O. Sanchez

  • C. Tromeur

  • B. Planquette

  • F. Couturaud

Medical Centers

  • Hôpital européen Georges Pompidou, Inserm UMRS_1140, Paris, Ile-de-France, France

  • ESPCI, Paris, Ale-de-France, France

  • CHRU Brest Morvan, Brest, Bretagne, France

  • CHU Besançon, Besançon, Franche-Comte, France

  • CHU Dijon, Dijon, Bourgogne, France

  • Hospices Civils de Lyon, LYON, Rhone-Alpes, France

  • HEGP, Inserm UMRS_1140, Paris, Ile-de-France, France

  • Innovative Therapies in Haemostasis, INSERM, Université de Paris, Paris, France, Paris, Ile-de-France, France

  • Department of Internal Medicine and Chest Diseases, CHU de Brest, Brest, Bretagne, France

  • ESPCI, Paris, Ale-de-France, France

  • Inserm, Univ Brest, CHRU Brest, UMR 1304, GETBO, Departement de Medecine Interne et Pneumologie, Brest, France, Brest, Bretagne, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved